Central to this process is endothelial cell (EC) dysfunction, which manifests as impaired nitric oxide (NO) bioavailability due to eNOS (endothelial nitric oxide synthase) uncoupling - a hallmark mechanism linking hemodynamic stress and lipid metabolic disorders to atherosclerotic plaque development (13). This evidence concerns the gene NOS3 and Disorder of lipid metabolism.